As large language models (LLMs) move from drafting to end-to-end manuscript production, the critical bottleneck shifts from generation to verification. According to a paper on arXiv (June 2026), fluent LLM output can hide fabricated citations, numbers that drift from source tables, and unmet reporting-guideline items. Existing tools generate without verifying, and self-critique inherits the blind spots that produce confident fabrication.
The Architecture
The paper describes an architecture pairing generation with verification, resting on three principles: decompose the workflow into self-contained skills, gate every stage transition with halt-on-failure, and resolve each integrity question with the cheapest sufficient mechanism. This approach uses a deterministic, re-executable check where one suffices, and a prose-level probe only where interpretation is unavoidable. The authors call this the determinism-where-possible split, organized as an integrity-gate taxonomy—the core contribution of the work.
Deterministic Verification
The architecture is realized as MedSci Skills, an open-source toolkit (MIT-licensed, v3.8.0) comprising 43 skills with a 21-detector deterministic tier. The system was evaluated on three public-dataset pipelines: STARD, PRISMA, and STROBE. Across all three pipelines, every content-hash manifest verified clean, and the gates surfaced real defects. In a seeded-defect ablation with 27 identical injected defects, the deterministic gates detected all 27 with no false positives on the matched clean fixtures, whereas a single-prompt LLM reviewer detected only 11—missing defects in code, bibliography, and style that prose hides.
Experimental Results
| Metric | Deterministic Gates | Single-Prompt LLM Reviewer |
|---|---|---|
| Injected defects detected | 27 out of 27 | 11 out of 27 |
| False positives | 0 | Not reported |
| Defects missed | 0 | 16 (code, bibliography, style) |
Implications for Enterprise AI
For enterprise technology leaders, the principle of "determinism-where-possible" offers a blueprint for verifiable AI in regulated workflows. The architecture yields an auditable, re-executable trail that exposes the evidence a human needs to check an LLM-assisted manuscript—feasibility and reproducibility evidence, not a claim of human-competitive quality. This approach could extend beyond clinical manuscripts to any domain where LLM output must be trusted, such as compliance documentation, technical reports, or supply chain contracts. The open-source release encourages adaptation, while the clear separation of deterministic checks from LLM-based probes provides a risk-managed path to automation.